#161924

Calu-6 Cell Line

Awaiting product image

Cat. #161924

Calu-6 Cell Line

Cat. #: 161924

Availability: 8-10 weeks

Organism: Human

Tissue: Unknown

Model: Tumourigenic

£575.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Enquire or request a quote

Contributor

Inventor: Jorgen Fogh

Institute: Memorial Sloan-Kettering Cancer Center (MSK)

Primary Citation: Wright et al. 1981. Journal of the National Cancer Institute. 66:239-247. PMID: 6936474.

Tool Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Calu-6 Cell Line
  • Cancer type: Lung cancer
  • Organism: Human
  • Gender: Female
  • Tissue: Unknown
  • Donor: This cell line was established in 1971 from lung metastasis in lung adenocarcinoma
  • Morphology: Epithelial
  • Growth properties: Adherent
  • Model: Tumourigenic
  • Model description: Tumourigenic in nude mice; forms poorly differentiated carcinoma
  • Products or characteristics of interest: Karyotype: The stemline chromosome number is hypotriploid and the 2S component occurred at 5.8%. Modal chromosome number is 59. Fourteen marker chromosomes (constitutive) were common to most S metaphases. No Y chromosome was detected in the QM stained preparation. Isoenzymes: AK-1, 1; ES-D, 1; G6PD, B; GLO-I, 2; Me-2, 1; PGM1, 2; PGM3, 1
  • Description: This cell line was established in 1971 from lung metastasis in lung adenocarcinoma. CaLu-6 is a human lung adenocarcinoma cell line.
  • Application: 3D cell culture; Cancer research
  • Biosafety level: 1

Applications

  • Application: 3D cell culture; Cancer research

Handling

  • Growth medium: EMEM supplemented with FBS to a final concentration of 10%
  • Temperature: 37° C
  • Atmosphere: 5% CO2 in air
  • Shipping conditions: Dry Ice
  • Storage medium: Complete growth medium supplemented with 5% (v/v) DMSO
  • Storage conditions: Vapor phase of liquid nitrogen
  • Str profiling: Amelogenin: XCSF1PO: 12D13S317: 11D16S539: 13D5S818: 11D7S820: 10TH01: 9TPOX: 8vWA: 17D3S1358: 16D21S11: 31D18S51: 12,16Penta_E: 5,14Penta_D: 13D8S1179: 10,14FGA: 22D19S433: 13D2S1338: 17,26

References

  • Wright et al. 1981. Journal of the National Cancer Institute. 66:239-247. PMID: 6936474.

Related Products

Cat #162441
Anti-CAR Whitlow Linker [1C3C3]

Cat. #162441

Anti-CAR Whitlow Linker [1C3C3]

View Tool
Cat #162440
Scientific figure containing flow cytometry histograms

Cat. #162440

Anti-CAR Whitlow Linker [1B3b]

View Tool
Cat #162439
Anti-CAR Whitlow Linker [1B4A1]

Cat. #162439

Anti-CAR Whitlow Linker [1B4A1]

View Tool

Related products

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.